Association between BAFF gene polymorphism and systemic lupus erythematosus: a meta-analysis by Qing Wu, Qin Zhang, Dong-Qing Ye

Subjects: “…BAFF…”
Get full text

Increased BAFF Levels in Children with Acute Brucellosis by Emine Hafize Erdeniz, Ozge Cevik

Subjects: Get full text

B cells and treatment progression in lupus nephritis by ZHANG Yue-qi, LIAO Xiao-hui

Subjects: Get full text

CCN1 promotes APRIL/BAFF signaling in esophageal squamous cell carcinoma but attenuates it in esophageal adenocarcinoma by Lingling Xing, Zhenyu Jiang, Ruize Xu, Tong Dang, Jinbao Wu, Jianyuan Chai, Xianmei Meng

Subjects: Get full text

The path less traveled: the non-canonical NF-κB pathway in systemic lupus erythematosus by Hilary Montano, Irving Coy Allen, Christopher M. Reilly

Subjects: Get full text

B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant by Claire Fritz, Daniel Feinberg, Akshaya Radhakrishnan, Kayla Klatt, E. Ricky Chan, Philip Rock, Richard Burack, Reshmi Parameswaran

Subjects: Get full text

Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sjögren’s syndrome by Anastasia V. Poznyak, Elena V. Gerasimova, Nikolay A. Orekhov, Amina Eldarovna Karimova, Maria Andreevna Vergun, Ksenia Olegovna Lapshina, Vasily N. Sukhorukov, Alexander N. Orekhov

Subjects: Get full text

Novel Treatment Paradigms: Primary IgA Nephropathy by Haresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung

Subjects: Get full text

BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study by Li Huang, Yingzi Huang, Jiamin Zeng, Huhai Zhang, Liping Chen, Yi Li, Hongwen Zhao, Xiaopeng Tang

Subjects: Get full text

Respiratory Syncytial Virus Induces B Cell Activating Factor (BAFF) in Airway Epithelium: A Potential Avenue for Mucosal Vaccine Development by Wael Alturaiki, Brian Flanagan

Subjects: “…BAFF…”
Get full text

INVESTIGATION OF DICER1 AND BAFF GENE MUTATIONS IN B-CELL NON-HODGKIN LYMPHOMA by Nurcan Çırak, Demet Akdeniz Ödemiş, Hülya Yazıcı

Subjects: Get full text

Efficacy of Telitacicept in treating IgA vasculitis nephritis: a two-case report by Shuang-xi Li, Rui-kang Hu, De-liang Kong, Jing Xu, Qi Bian, Zhi-Yong Guo, Xiao-bin Mei

Subjects: Get full text

Causal relationship between Baff-R expression and normal pressure hydrocephalus: insights from Mendelian randomization analysis by Wencai Wang, Luyao Ma, Menghao Liu, Yongqiang Zhao, Wei Ye, Xianfeng Li

Subjects: Get full text

Protective Effects of <i>Physalis angulata</i> on Podocythopathies Through B-Cell-Activating Factor Inhibition in Doxorubicin-Induced Nephrotic Syndrome Rat Model by Astrid K. Kardani, Loeki E. Fitri, Nur Samsu, Krisni Subandiyah

Subjects: Get full text

Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients by Özlem Kanburoğlu Meletli, Alev Altınova, Başak Bolayır, Resul Karakuş, Meriç Coşkun, Mehmet Muhittin Yalçın, Müjde Aktürk, İlhan Yetkin, Füsun Saadet Toruner

Subjects: Get full text

Impact of NF-κB and reactive oxygen species on intracellular BAFF/APRIL expression in ANCA-associated vasculitis: focusing on the effect of resveratrol by Yasuhiro Shimojima, Dai Kishida, Takanori Ichikawa, Yoshiki Sekijima

Subjects: Get full text

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS by E. V. Suponitskya, E. N. Aleksandrova, E. L. Nasonov

Subjects: “…baff/blys…”
Get full text

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS by T. A. Panafidina, M. A. Sokhova, T. V. Popkova, M. V. Cherkasova, A. A. Novikov, E. N. Aleksandrova, E. L. Nasonov

Subjects: Get full text

Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy by Zhaohui Li, Ping Chen, Ying Zhang, Juan Chen, Shanshan Zheng, Wenbin Li, Lijun Tang, Yipeng Liu, Na Zhao

Subjects: “…B-cell activation factor (BAFF)…”
Get full text

Povetacicept (ALPN-303; TACI vTD-Fc), an enhanced, potent dual inhibitor of BAFF and APRIL, ameliorates experimental autoimmune myasthenia gravis in C57BL/6N mice by Elena Rinaldi, Elisa Puleo, Alessandra Consonni, Martina Miglietti, Renato Mantegazza, NingXin Wang, Stanford L. Peng, Katherine E. Lewis, Stacey R. Dillon, Fulvio Baggi

Subjects: “…BAFF - B-cell activating factor…”
Get full text